|
Solvent |
mg/mL |
mM |
comments |
| Solubility |
| DMF |
0.5 |
1.00 |
|
| DMSO |
0.3 |
0.50 |
|
| Ethanol |
2.0 |
4.01 |
|
| Ethanol:PBS (pH 7.2) (1:1) |
0.5 |
1.00 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
498.49
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1. Chen, J.W., Dodia, C., Feinstein, S.I., et al. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. The Journal of Biological Chemisty 275(37), 28421-28427 (2000).
2. Fisher, A.B., Dodia, C., Feinstein, S.I., et al. Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. Journal of Lipid Research 46(6), 1248-1256 (2005).
3. Fisher, A.B., and Dodia, C. Role of acidic Ca2+-independent phospholipase A2 in synthesis of lung dipalmitoyl phosphatidylcholine. American Journal of Physiology 272, L238-L243 (1997).
4. Fisher, A.B., and Dodia, C. Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes. Journal of Lipid Research 37, 1057-1064 (1996).
5. Kim, T.S., Sundaresh, C.S., Feinstein, S.I., et al. Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein. The Journal of Biological Chemisty 272, 2542-2550 (1997).
6. Fisher, A.B., Dodia, C., Chander, A., et al. A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung. Biochemistry Journal 288(Pt 2), 407-411 (1992).
7. Lee, I., Dodia, C., Chatterjee, S., et al. Protection against LPS-induced acute lung injury by a mechanism-based inhibitor of NADPH oxidase (type 2). American Journal of Physiology.Lung Cellular and Molecular Physiology 306, L635-L644 (2014).
8. Wu, Y., Feinstein, S.I., Manevich, Y., et al. Mitogen-activated protein kinase-mediated phosphorylation of peroxiredoxin 6 regulates its phospholipase A2 activity. Biochem. 419(3), 669-679 (2009).
